SCHEMBL601176

SCHEMBL601176

O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(F)c(F)c21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 2/20 0.59
MEN1 O00255 2/20 0.59
HTT P42858 2/20 0.59
KMT2A Q03164 2/20 0.59
CYP2C19 P33261 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
SMAD3 P84022 1/20 0.59
PRMT1 Q99873 1/20 0.59
ACE2 Q9BYF1 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ALOX12 P18054 2/20 0.56
ALDH1A1 P00352 2/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
BRCA1 P38398 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4576798 0.91 FTO (0.58) FTOMAPTHPGDMEN1HTT
SCHEMBL5052755 0.86 FTO (0.63) FTOMAPTHPGDMEN1HTT
SCHEMBL6535901 0.85 HPGD (0.55) FTOMAPTHPGDMEN1HTT
SCHEMBL7110600 0.84 HPGD (0.63) FTOMAPTHPGDMEN1HTT
SCHEMBL1987812 0.81 HPGD (0.54) FTOMAPTHPGDMEN1HTT
SCHEMBL1608876 0.81 HPGD (0.63) FTOMAPTHPGDMEN1HTT
SCHEMBL6662140 0.81 FTO (0.74) FTOMAPTHPGDMEN1HTT
SCHEMBL4056456 0.81 FTO (0.62) FTOMAPTHPGDMEN1HTT
SCHEMBL139173 0.81 FTO (0.65) FTOMAPTHPGDMEN1HTT
SCHEMBL3189664 0.81 FTO (0.66) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119744345-A Compositions and methods for single well multiple calibration and compensation 弹弓生物科学公司 2025-04-01 CN claimed
US-9487817-B2 Systems and methods for feedstock quality assessment POET RESEARCH, INC. (US) 2016-11-08 US claimed
EP-2649195-B1 METHODS FOR FEEDSTOCK QUALITY ASSESSMENT POET RES INC (US) 2015-12-02 EP claimed
US-8748159-B2 Method and apparatus for viable and nonviable prokaryotic and eukaryotic cell quantitation GENPRIME, INC. (US) 2014-06-10 US claimed
US-20130337483-A1 SYSTEMS AND METHODS FOR FEEDSTOCK QUALITY ASSESSMENT POET RESEARCH, INC. (US) 2013-12-19 US claimed
EP-2649195-A2 SYSTEMS AND METHODS FOR FEEDSTOCK QUALITY ASSESSMENT POET Research, Inc. (US) 2013-10-16 EP claimed
US-20120164677-A1 METHOD AND APPARATUS FOR VIABLE AND NONVIABLE PROKARYOTIC AND EUKARYOTIC CELL QUANTITATION GENPRIME, INC. (US) 2012-06-28 US claimed
WO-2012078885-A2 SYSTEMS AND METHODS FOR FEEDSTOCK QUALITY ASSESSMENT POET RESEARCH, INC. (US) 2012-06-14 WO claimed
US-20110136159-A1 METHOD AND APPARATUS FOR VIABLE AND NONVIABLE PROKARYOTIC AND EUKARYOTIC CELL QUANTITATION GENPRIME, INC. (US) 2011-06-09 US claimed
US-7906295-B2 Method and apparatus for viable and nonviable prokaryotic and eukaryotic cell quantitation GENPRIME, INC. (US) 2011-03-15 US claimed
US-20060105410-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US claimed
US-20060105412-A1 Sulfonate compound and fluorescent probe using the same OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2006-05-18 US claimed
EP-1650200-A1 SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME Osaka Industrial Promotion Organization (JP) 2006-04-26 EP claimed
US-20050282244-A1 Detecting the total cell count in a sample, contacting cells with molecule or dye that is detectably altered by enzymatic activity of a viable cell, detecting the dye or molecule, thereby detecting viable cell number, comparing with total GENPRIME, INC. (US) 2005-12-22 US claimed
US-6900891-B2 Optical sensors for the detection of nitric oxide THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2005-05-31 US claimed
EP-1532988-A2 Antibody dye conjugates for the intraoperative delimitation of tumors Schering AG (DE) 2005-05-25 EP claimed
US-20050014197-A1 Compositions and methods for detection and isolation of phosphorylated molecules MOLECULAR PROBES, INC. 2005-01-20 US claimed
US-20040190813-A1 Optical sensors for the detection of nitric oxide THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2004-09-30 US claimed
EP-1214099-A1 ANTIBODY DYE CONJUGATES FOR BINDING TO TARGET STRUCTURES OF ANGIOGENESIS IN ORDER TO INTRAOPERATIVELY DEPICT TUMOR PERIPHERIES SCHERING AKTIENGESELLSCHAFT (DE) 2002-06-19 EP claimed
WO-2001023005-A1 ANTIBODY DYE CONJUGATES FOR BINDING TO TARGET STRUCTURES OF ANGIOGENESIS IN ORDER TO INTRAOPERATIVELY DEPICT TUMOR PERIPHERIES SCHERING AKTIENGESELLSCHAFT (DE) 2001-04-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060105410-A1 Sulfonate compound and fluorescent probe using the same BRS3, NCOA3, NR4A3 FTO 1653/4885MAPT 4674/4885HPGD 4765/4885
US-20060105412-A1 Sulfonate compound and fluorescent probe using the same SLCO1B3, CBR3, SLCO2B1 FTO 1304/4885MAPT 4468/4885HPGD 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.